Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP ...
High-grade serous ovarian cancer (HGSOC) and triple-negative breast cancer (TNBC) share clinical and genomic characteristics, such as poor prognosis, homologous recombination (HR) deficiencies and potential immunoreactivity1–4. There is an urgent unmet …